Bio News
Sandoz has received Brazilian marketing approval for the synthetic semaglutide product ‘Owoji,’ which can be stored at room temperature for 42 days. The product maintains stability for up to 42 days at temperatures of up to 30°C after first use, improving convenience for patients. Sandoz plans to launch the product in the second half of this year and enter Brazil’s GLP-1 treatment market.
Biobook Team
biobookmedia@biobook.co.krIonkura Reports 20.8-Month Median Survival in Phase 1 Trial for Metastatic Eye Cancer
Verastem’s VS-7375 Shows Response Rates of Up to 50% in Pancreatic Cancer; Phase 3 Trial to Begin This Year
Pfizer to Co-Develop Sec61 Inhibitors With Enodia in Deal Worth Up to $500 Million
Galderma to Acquire ZO Skin Health for $1.5 Billion, Expanding Dermatology Portfolio
Verdiva halts GLP-1 transition trial, citing ‘market changes’
Stryker to Invest $400 Million in CMR Surgical, Expand Robotic Surgery
